Volume 40, Number 5, September-October 2010

Table of Contents

Personalized Medicine: Will it work? Where will it take us?

Field Notes

Field Notes

p. c2
|

From the Editor

Public and Private

p. 2
|

Another Voice

Strange Deathbedfellows

p. 3
|

Letters

Exitus Acta Probat?

p. 4
|

To the Editor

p. 4
|

To the Editor

pp. 4-5
|

Michael L. Gross replies

p. 5
|

In Practice

One City, Two Worlds

pp. 6-7
|

At Law

The National Individual Health Insurance Mandate

pp. 8-9
|

Policy and Politics

Against One-Size-Fits-All Research Ethics

pp. 10-11
|

When Time Won't Tell

p. 12
|

Commentary

pp. 12-13
|

Commentary

p. 13
|

Essays

The Prospects for Personalized Medicine

pp. 14-16
|

Personalized Medicine's Ragged Edge

pp. 16-18
|

Personalized Cancer Care in an Age of Anxiety

pp. 18-21
|

Wanted: Human Biospecimens

pp. 21-23
|

Direct-to-Consumer Genetic Tests and the Right to Know

pp. 24-25
|

Hospice and Physician-Assisted Death

Hospice and Physician-Assisted Death: Collaboration, Compliance, and Complicity

pp. 26-35
|

Can We Improve Treatment Decision-Making for Incapacitated Patients?

Can We Improve Treatment Decision-Making for Incapacitated Patients?

pp. 36-45
|

Exploring Communal Health through Law

pp. 46-47
|

Contributors

Contributors

p. 48
|

Perspective

100 Years Later, the Flexner Report Is Still Relevant

p. c3
|